Yes. We are currently planning an in-person meeting. There is no option for virtual presentation and all Presenting Authors of selected abstracts must be available to attend the ACAAI 2023 Annual Meeting in Anaheim, CA.
Research – Open: April 3, 2023 – Close: July 10, 2023 - 5:00 pm (Central)
Medically Challenging Cases – Open: April 3, 2023 – Close: August 1, 2023 - 5:00 pm (Central)
Note: Due to publication deadlines, the abstract submission deadlines will not be extended.
There is a $60 non-refundable fee for each abstract submission.
No changes can be made after the deadline.
No. Abstracts can be submitted by Members and Non-Members of ACAAI.
Yes. A non-Author can submit and be the main point of contact for an abstract.
Click here for guidance on adding Authors to your Abstract.
ACAAI will be accepting late-breaking abstracts meeting specific protocols for the 2023 Annual Scientific. Click here for important information regarding late-breaking abstract submissions.
Research Abstracts are allowed a total of 8 Authors.
Medically Challenging Case Abstracts are allowed a total of 5 Authors.
No. You are welcome to submit an unlimited number of abstracts. However, an Author can only be listed as a Presenting Author on one abstract.
Yes. Any listed author who has completed a Disclosure by the submission deadline date can become the Presenting Author. Note, however, that the Presenting Author as shown within our system as of the deadline date, will appear as the Presenting Author in any online or print publication of the abstract.
Yes. All disclosures must be fully completed by the abstract deadline. Any author who has failed to complete their disclosure will be removed from the abstract and will not appear in any published/online use of the abstract.
Once the Submitter has entered the names and email address(es) of the author(s) and pressed the “submit” or “save and edit later” button, an email is automatically sent to each listed author that includes a link to their individual disclosures.
Note: Each time the submitter clicks the “submit” or “save and edit later” button, a new email, with a modified link, will be sent to any author who has not completed their disclosure. All previously sent links will be rendered invalid.
Login to your abstract. Click the edit abstract icon. Click the "Save and Edit Later" or "Submit Abstract" button. Any authors who have not completed a disclosure will be sent an email with a link to complete their disclosure.
The abstract submitter will be notified of the decision in late-August/early-September. It is the responsibility of the abstract submitter to notify any additional authors.
All accepted abstracts will be published in the ACAAI’s Annals of Allergy, Asthma & Immunology – November, 2023 Supplement. ePosters with audio/video recording will be available for online viewing.
All accepted abstracts, ePosters, and oral presentation slides are embargoed until November 9, 2023. Authors are permitted to share only the abstract title, date of oral/ePoster presentation, and presenter name in any communication prior to November 9, 2023.
Please contact Hollis Heavenrich-Jones, Director of Public Relations at hollisheavenrich-jones@acaai.org for information and assistance.
General ePosters can include a QR Code or Bar Code only to direct the viewer to additional education information. QR Codes and Bar Codes cannot direct the viewer to any promotional materials or information.
ePosters that are created from abstracts presented during an Oral Abstract session cannot include a QR Code or Bar Code.
No. QR Codes and/or Bar Codes cannot be included in any presentation during educational sessions presented during the Annual Meeting.
Abstracts can be withdrawn at anytime during the submission period. No abstracts can be withdrawn after the close of the submission period. Requests for withdrawal must be submitted in writing to maureenknight@acaai.org.
| No FAQ Found |